Pharmaceutical switch is a tonic ... for some

Article Abstract:

The Australian government has replaced the Pharmaceutical Benefits Scheme (PBS), a $1 billion program under which 17 pharmaceutical companies were compensated for low drug prices paid by the government in exchange for research and development (R&D) commitments and production value-added (PVA). Its replacement, the Pharmaceutical Industry Investment Program (PIIP), will provide $300 million in grants to nine companies over five years. PIIP still provides compensation and requires in return $1.5 billion in R&D and PVA. Australia's pharmaceutical industry is a $5 billion business, with $1 billion in export sales a year.

Drugs & Pharmaceuticals, Pharmaceutical and Medicine Manufacturing, Drugs, Regulation, Licensing, and Inspection of Miscellaneous Commercial Sectors, Business Aid & Regulation NEC, Pharmaceutical industry, Finance, Business assistance

---

Streetkids strut some niche ideas

Article Abstract:

Speakout was established in 1996 in Marrickville, Australia, with a $100,000 Australian grant from the Australian Youth Foundation, a $50,000 Australian grant from the federal government and backing from The Body Shop. In 1999, the firm produces some of the most popular streetwear in Australia. Troubled and disadvantaged youth are given experience to help with future employment.

APPAREL AND OTHER TEXTILE PRODUCTS, Apparel & Related Products, Apparel Manufacturing, Clothing industry, Company Profile, Speakout

---

Gates open for skills

Article Abstract:

The issue of Australian companies such as MaxiTrans to recruit overseas workers is examined.

Corporations, Personnel administration, Recruiting, Alien labor, Company personnel management, Industry hiring, Alien labour, Foreign labor

Similar abstracts:

• Abstracts: Personal technology: online drugstores offer some remedies and a few headaches. Personal technology: Now, you can police your kids' desktop, but in a nice way
• Abstracts: SangStat wins patent for cyclosporine, setting stage for a battle with Novartis. SangStat wins FDA approval to market drug for use after organ transplants
• Abstracts: Take care if a tax break is your main motive for borrowing. More doubts about super choice
• Abstracts: Technologically neutral is the only way to be. There's method in Compaq biting the hands that feed. The ACCC should teach, not use the cane
• Abstracts: Bjorn again ... and again. Minstrels get tickets to wander. Right placement, right time

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.